Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                Guidance & Regulations

Guidance & Regulations

                        


                        Guidance for Industry
          Policies & Procedures Manual Home
          Animal & Veterinary
          Guidance & Regulations
          Animal Drug Availability Act of 1996Guidance & Regulations Animal Drug Availability Act of 1996
  
  	
    Share
    Post
    Linkedin

    Email
    PrintThe Animal Drug Availability Act (H.R. 2508) (“ADAA”), signed by the President on October 9, 1996, amended the Federal Food, Drug, and Cosmetic Act to provide new flexibility to the way FDA regulates new animal drugs and medicated feeds.

The law was intended to increase the number of approved new animal drugs on the market and was supported by FDA's Center for Veterinary Medicine and a coalition of animal industry groups which included manufacturers of animal health products, veterinarians, and livestock producers. ADAA made changes that were intended to benefit the animal health industry and the nation's animals without compromising FDA's mission to protect the public health. The changes introduced by ADAA include:

amended the definition of substantial evidence of effectiveness, making the process FDA uses to evaluate and approve new animal drugs more flexible. This change eliminated the requirement for field studies and expanded the types of studies that FDA could consider in support of a finding of substantial evidence of effectiveness.
	provided for more interaction between animal drug sponsors and the FDA during the drug development process. The law requires FDA to grant a presubmission conference, if requested by the sponsor, to discuss the drug development at its earliest stages. The purpose of a presubmission conference is for FDA and the sponsor to agree on the data needed to establish safety and effectiveness, and the types of studies that can be conducted to generate such data.
	provided a procedure for establishing import tolerances for residues of new animal drugs not approved or conditionally approved for use in the United States but lawfully used in other countries and present in imported, animal-derived food and food products. Import tolerances provide a basis for importing and legally marketing such animal-derived food and food products in the United States.
	created a new category of drugs, "Veterinary Feed Directive Drugs," that allows the approval and use of new animal drugs in animal feed, on a veterinarian's order.
	permitted a range of acceptable/recommended doses to appear on new animal drug product labeling, rather than one optimum dose.
	In addition, the law gives direction to FDA on how to review supplements that seek to add a minor use or minor species indication to an approved application.Since enactment in 1996, ADAA’s provisions have been implemented by FDA in the following regulations:

21 CFR § 514.4 – Substantial evidence
	21 CFR § 514.5 – Presubmission conferences
	21 CFR § 514.117 – Adequate and well-controlled studies
	21 CFR § 558.6 – Veterinary feed directive drugs
	21 CFR § 510.201 et seq. – Import Tolerances for Residues of Unapproved New Animal Drugs in Food

                                                                                  Content current as of:
      04/24/2023Guidance & Regulations

          
                        


                        Guidance for Industry
          Policies & Procedures Manual
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop